Real Estate · Land
Sunway Healthcare Acquires Land in Johor for RM781.6 Million Hospital Project
The Malaysian healthcare operator is purchasing four land parcels near Singapore's border to build a 410-bed tertiary facility, marking its first expansion into Johor state.

KEY TAKEAWAYS
- ·Sunway Healthcare is purchasing four land parcels in Sunway City Iskandar Puteri for RM45.37 million to build a 410-bed tertiary hospital at an estimated cost of RM781.6 million.
- ·The project marks Sunway Healthcare's first expansion into Johor state, targeting unmet healthcare demand in Malaysia's southern region approximately five kilometers from the Singapore border.
- ·The land acquisition is expected to complete in the second quarter of 2027, financed through internal funds and bank borrowings without requiring shareholder approval.
Strategic Southern Expansion
Sunway Healthcare has agreed to acquire four land parcels in Sunway City Iskandar Puteri for RM45.37 million (US$11.1 million), setting the stage for a RM781.6 million hospital development that will anchor the group's entry into Malaysia's Johor state.
The transaction, disclosed in a Wednesday bourse filing, involves Sunway Medical Centre, a 99.9%-owned subsidiary, purchasing the plots from three affiliated Sunway Group entities: Sunway Marketplace, Sunway Parkview, and Sunway Iskandar. The company plans to construct a 410-bed tertiary hospital on the site, targeting what it describes as unmet healthcare demand in Malaysia's southern corridor.
According to Sunway Healthcare, the acquisition supports the group's broader strategy to expand its tertiary hospital network across key Malaysian markets. The site sits within the 2,000-acre Sunway City Iskandar Puteri township, positioned approximately five kilometers from the Second Link checkpoint connecting Johor to Tuas in western Singapore.
Financing and Timeline
Sunway Healthcare will fund the land purchase through a mix of internal capital and bank borrowings. The deal is structured as a related-party transaction and does not require shareholder approval under Malaysian regulations.
Completion is scheduled for the second quarter of 2027. Once operational, the facility will add significantly to Sunway Healthcare's bed capacity, which stood at 1,982 across 1,805 licensed beds as of March 31.
Market Performance and Ownership
Sunway Healthcare's shares closed at RM1.92 on Wednesday, down 1.54%, valuing the company at RM22.1 billion. The healthcare arm debuted on Bursa Malaysia earlier this year in what marked the country's largest initial public offering in nearly a decade.
The company reported first-quarter revenues of RM587 million, a 24% increase year-on-year. However, net profit fell 14% to RM33.3 million, pressured by higher depreciation and finance costs tied to recent expansion projects.
The Sunway Group Context
Sunway Healthcare operates as a unit of Sunway Group, one of Malaysia's largest conglomerates with diversified interests in construction, property development, education, and infrastructure. Jeffrey Cheah, the group's founder and chairman, ranks as Malaysia's eighth-richest individual with a net worth of US$5.3 billion, according to Forbes data from late April.
The Johor project reflects the group's integrated township model, where healthcare, education, and commercial real estate assets cluster within master-planned developments. Sunway City Iskandar Puteri follows this blueprint, combining residential, retail, and institutional components across its 809-hectare footprint.
Regional Healthcare Dynamics
The hospital's proximity to Singapore positions it within a cross-border healthcare corridor that has long drawn Malaysian medical operators. Johor's southern region hosts a growing population of commuters and residents with ties to Singapore, creating demand for tertiary care closer to the border than Kuala Lumpur-based facilities.
Sunway Healthcare's move comes as Malaysia's private hospital sector navigates post-pandemic patient volume shifts and capital intensity pressures. The company's first-quarter results illustrate the tension: revenue growth driven by patient throughput and case mix improvements, offset by the depreciation and interest expense burden of building out capacity in a capital-intensive industry.
The RM781.6 million price tag for the 410-bed hospital implies a per-bed capital cost of approximately RM1.9 million, in line with recent tertiary hospital developments in Malaysia's major urban markets. The investment will test Sunway Healthcare's ability to ramp occupancy and case complexity quickly enough to service the debt and generate returns that justify the deployment.
What Comes Next
Sunway Healthcare has not disclosed a construction timeline beyond the land acquisition schedule. Industry benchmarks suggest a 30-to-36-month build period for a facility of this scale, pointing to a potential 2030 opening if ground breaks in late 2027.
The company will need to secure hospital licensing from Johor state health authorities and recruit specialist teams to staff the tertiary services that differentiate the project from community hospitals. Its existing network spans six hospitals and four medical centers, providing a talent pipeline and operational playbook, but Johor's competitive landscape includes established players with entrenched referral networks.
For Jeffrey Cheah's broader conglomerate ambitions, the hospital anchors another mixed-use township and reinforces Sunway's template of vertically integrating real estate, healthcare, and education assets within single developments. Whether the model scales profitably in Johor will hinge on population growth trajectories, cross-border patient flows, and the group's execution on cost and quality benchmarks that determine reimbursement rates and reputation in a market where patients vote with their feet.
RELATED STORIES
Spot something wrong? Email editor@briefasia.com. We log every correction publicly.



